Keratopathy in Patients with Adenoviral Keratoconjunctivitis: Evaluation of the Effectiveness of Modern Interferon Preparations
It is considered, that one of the main directions of treatment of adenovirus conjunctivitis is the appointment of interferon alpha-2b in combination with diphenhydramine, which until recently was provided by the only original drug. In 2020, the first generic drug, Interferon-Oftalmo, would be regist...
| Published in: | Oftalʹmologiâ |
|---|---|
| Main Authors: | E. A. Drozdova, S. Yu. Golubev, V. V. Brzheskiy, E. A. Romanova, V. A. Kireeva, E. V. Berdnikova |
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2023-04-01
|
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/2057 |
Similar Items
The effectiveness of Interferon-Ophthalmo, an antiviral and immunotropic drug, in the treatment of adenoviral ophthalmic infections
by: E. V. Yani, et al.
Published: (2023-03-01)
by: E. V. Yani, et al.
Published: (2023-03-01)
FEATURES OF THE CLINICAL COURSE, OBSERVATION AND PREVENTION OF ADENOVIRAL EPIDEMIC KERATOCONJUNCTIVITIS IN INFANT IN THE PERINATAL CENTER
by: I. B. Astasheva
Published: (2017-12-01)
by: I. B. Astasheva
Published: (2017-12-01)
Effect of Manuka Honey Eye Drops among Patients Diagnosed with Adenoviral Keratoconjunctivitis in The Gaza Strip
by: Aysha F. Alagha, et al.
Published: (2023-07-01)
by: Aysha F. Alagha, et al.
Published: (2023-07-01)
Assessment of efficiency and safety of complex therapy of acute adenoviral diseases in young people
by: N. A. Malyshev, et al.
Published: (2021-06-01)
by: N. A. Malyshev, et al.
Published: (2021-06-01)
FEATURES OF 0.05% CYCLOSPORINE (RESTASIS) APPLICATION IN TREATMENT OF RECURRENT INFILTRATIVE ADENOVIRAL KERATITIS
by: D. Y. Maychuk, et al.
Published: (2015-10-01)
by: D. Y. Maychuk, et al.
Published: (2015-10-01)
Reserve drug as first-line management: Topical interferon α-2b for vernal keratoconjunctivitis
by: Saurabh Ramdas Haral, et al.
Published: (2024-03-01)
by: Saurabh Ramdas Haral, et al.
Published: (2024-03-01)
Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis
by: Rahul Bhargava, et al.
Published: (2019-01-01)
by: Rahul Bhargava, et al.
Published: (2019-01-01)
<italic>In Vivo</italic> Confocal Microscopy Analysis of the Corneal Layers in Adenoviral Epidemic Keratoconjunctivitis
by: Sevgi Subaşı, et al.
Published: (2018-12-01)
by: Sevgi Subaşı, et al.
Published: (2018-12-01)
Detection of Human Adenovirus from Clinical Samples of Conjunctivitis by Real-time PCR: A Cross-sectional Descriptive Study
by: Ashish Anshuman, et al.
Published: (2024-11-01)
by: Ashish Anshuman, et al.
Published: (2024-11-01)
Epidemic Keratoconjunctivitis in Al-Ramadi City
by: Zeina M. Al-Sabti
Published: (2014-04-01)
by: Zeina M. Al-Sabti
Published: (2014-04-01)
The effect of povidone-iodine 2% eye drops in the treatment of adenoviral keratoconjunctivitis
by: Mohammad Soleimani, et al.
Published: (2023-01-01)
by: Mohammad Soleimani, et al.
Published: (2023-01-01)
PREVENTION OF ADENOVIRAL EYE INFECTION - REVIEW
by: Katarina Mirjane Janicijevic, et al.
Published: (2017-04-01)
by: Katarina Mirjane Janicijevic, et al.
Published: (2017-04-01)
An Update on Viral Conjunctivitis Treatment Strategies: A Narrative Literature Review
by: Maheshver Shunmugam, et al.
Published: (2025-07-01)
by: Maheshver Shunmugam, et al.
Published: (2025-07-01)
Evaluating anterior corneal surface using Placido ring mires for irregular astigmatism in refractory corneal subepithelial infiltrates after adenoviral conjunctivitis
by: Noriko Toyokawa, et al.
Published: (2024-11-01)
by: Noriko Toyokawa, et al.
Published: (2024-11-01)
Comparison between the Efficacy and Tolerability of Polyvinylpyrrolidone-Iodine Eye Drops 0.6% and 1% in Adenoviral Keratoconjunctivitis: A Randomized Clinical Trial
by: Ali Makateb, et al.
Published: (2024-08-01)
by: Ali Makateb, et al.
Published: (2024-08-01)
Efficacy of differentiated targeted interferon and immunomodulatory therapy focused on pathological immunophenotypes in patients with atypical chronic active herpesvirus infections
by: I. V. Nesterova, et al.
Published: (2024-03-01)
by: I. V. Nesterova, et al.
Published: (2024-03-01)
On the prevalence of vernal keratoconjunctivitis and current possibilities of treatment
by: V. V. Brzheskiy
Published: (2018-10-01)
by: V. V. Brzheskiy
Published: (2018-10-01)
INFECTIOUS BOVINE KERATOCONJUNCTIVITIS
by: Kapustin A.V., et al.
Published: (2020-12-01)
by: Kapustin A.V., et al.
Published: (2020-12-01)
The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)
Evaluating the Efficacy of Topical Tacrolimus Alone and in Combination with Prednisolone for Treating Subepithelial Infiltrates in Epidemic Keratoconjunctivitis
by: Emine Esra Karaca, et al.
Published: (2025-04-01)
by: Emine Esra Karaca, et al.
Published: (2025-04-01)
The molecular epidemiology, genotyping, and clinical manifestation of prevalent adenovirus infection during the epidemic keratoconjunctivitis, South of Iran
by: Vahidreza Afrasiabi, et al.
Published: (2023-03-01)
by: Vahidreza Afrasiabi, et al.
Published: (2023-03-01)
Emergency management: exposure keratopathy
by: Wanjiku Mathenge
Published: (2018-11-01)
by: Wanjiku Mathenge
Published: (2018-11-01)
Epidemic Keratoconjunctivitis: A Growing Concern in Pakistan
by: Nafia Hijab, et al.
Published: (2024-07-01)
by: Nafia Hijab, et al.
Published: (2024-07-01)
In Vivo Confocal Microscopic Findings of Subepithelial Infiltrates Associated with Epidemic Keratoconjunctivitis
by: Sibel Kocabeyoğlu, et al.
Published: (2015-05-01)
by: Sibel Kocabeyoğlu, et al.
Published: (2015-05-01)
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
by: Ekramy E. Sayedahmed, et al.
Published: (2020-10-01)
by: Ekramy E. Sayedahmed, et al.
Published: (2020-10-01)
Penetrating Keratoplasty For Treatment Of Bullous Keratopathy
by: Snezhana V. Murgova, et al.
Published: (2015-12-01)
by: Snezhana V. Murgova, et al.
Published: (2015-12-01)
Evidence based use of antibiotics in epidemic keratoconjunctivitis to prevent development of microbial resistance
by: Shalini Kumari, et al.
Published: (2025-01-01)
by: Shalini Kumari, et al.
Published: (2025-01-01)
The Therapeutic Potential of Insulin Eye Drops in Neurotrophic Keratopathy: A Comprehensive Review
by: Roxana Scripcă, et al.
Published: (2025-07-01)
by: Roxana Scripcă, et al.
Published: (2025-07-01)
Clinical and virological analysis of epidemic keratoconjunctivitis caused by adenovirus type 54 in a regional ophthalmic clinic in Kyushu, Japan
by: Uemura T, et al.
Published: (2018-03-01)
by: Uemura T, et al.
Published: (2018-03-01)
Pattern of presentation and laboratory findings of patients with epidemic keratoconjunctivitis in the 2023 outbreak in North India: A hospital-based analysis
by: Amit Mohan, et al.
Published: (2024-01-01)
by: Amit Mohan, et al.
Published: (2024-01-01)
Cyclosporine A and autologous serum efficacy for treatment of vernal keratoconjunctivitis
by: Ahmed Esmail, et al.
Published: (2024-05-01)
by: Ahmed Esmail, et al.
Published: (2024-05-01)
Interferon Status and Choice of Interferons Inducers in Frequently Ill Children
by: M. S. Savenkovа, et al.
Published: (2016-06-01)
by: M. S. Savenkovа, et al.
Published: (2016-06-01)
Interferon status at the women with recurrent genital herpes in combined liposomal RNA treatment
by: A. Sh. Makhmutkhodzhayev, et al.
Published: (2012-06-01)
by: A. Sh. Makhmutkhodzhayev, et al.
Published: (2012-06-01)
Insights Into Type I and III Interferons in Asthma and Exacerbations
by: Helen E. Rich, et al.
Published: (2020-09-01)
by: Helen E. Rich, et al.
Published: (2020-09-01)
A complicated course of the membranous form of epidemic keratoconjunctivitis. A case report
by: A. E. Babushkin, et al.
Published: (2022-07-01)
by: A. E. Babushkin, et al.
Published: (2022-07-01)
Characteristics of measles keratoconjunctivitis in adults
by: O.N. Ivanova, et al.
Published: (2018-02-01)
by: O.N. Ivanova, et al.
Published: (2018-02-01)
ACTIVATION OF SYNTHESIS OF ENDOGENOUS INTERFERON (REVIEW)
by: V. V. Poloskov, et al.
Published: (2019-01-01)
by: V. V. Poloskov, et al.
Published: (2019-01-01)
Rebamipide 2% Ophthalmic Suspension for the Treatment of Allergic Keratoconjunctivitis: A Hospital Based Study
by: Munish Dhawan, et al.
Published: (2016-04-01)
by: Munish Dhawan, et al.
Published: (2016-04-01)
ADMINISTRATION CRITERIA FOR INTERFERON-BASED DRUGS AND ITS INDUCERS IN ACUTE RESPIRATORY INFECTIONS IN CHILDREN
by: E. G. Golovacheva, et al.
Published: (2014-07-01)
by: E. G. Golovacheva, et al.
Published: (2014-07-01)
The evolution of interferon therapy in multiple sclerosis
by: O. V. Boyko, et al.
Published: (2023-08-01)
by: O. V. Boyko, et al.
Published: (2023-08-01)
Similar Items
-
The effectiveness of Interferon-Ophthalmo, an antiviral and immunotropic drug, in the treatment of adenoviral ophthalmic infections
by: E. V. Yani, et al.
Published: (2023-03-01) -
FEATURES OF THE CLINICAL COURSE, OBSERVATION AND PREVENTION OF ADENOVIRAL EPIDEMIC KERATOCONJUNCTIVITIS IN INFANT IN THE PERINATAL CENTER
by: I. B. Astasheva
Published: (2017-12-01) -
Effect of Manuka Honey Eye Drops among Patients Diagnosed with Adenoviral Keratoconjunctivitis in The Gaza Strip
by: Aysha F. Alagha, et al.
Published: (2023-07-01) -
Assessment of efficiency and safety of complex therapy of acute adenoviral diseases in young people
by: N. A. Malyshev, et al.
Published: (2021-06-01) -
FEATURES OF 0.05% CYCLOSPORINE (RESTASIS) APPLICATION IN TREATMENT OF RECURRENT INFILTRATIVE ADENOVIRAL KERATITIS
by: D. Y. Maychuk, et al.
Published: (2015-10-01)
